Gefitinib

2 Drugs classified under this active ingredient

EGFR Inhibitor. Gefitinib 250 mg.
F.C. TAB.:30. 250 mg (1 tab.)×1/d with / without food. See lit.
Tmt. of  adult pts. with local. advanced or metastat. Non‐small cell lung cancer (NSCLC) with activat. mutations of EGFR‐TK.
C/I: Hypersens.
Lact.

 

EGFR Inhibitor. Gefitinib 250 mg.
F.C. TABS: 30. Swall. whole 1 tab dly, with/
out food, as monother. in advanced
non-small-cell lung cancer (NSCLC)
prev. receiv. tmt. with cytotox.
chemother. Not recommend. child/
adolesc. No adjust reqd. in pt. age,
bdy. wt., gender, ethnicity, ren. funct.
Poorly tol. diarrh./skin adverse drug reacts: Brief (up to 14 days) ther.
interrupt foll. by reinstate 250 mg
dose.
Tmt. local advanced/metastat. NSCLC
who have prev. received chemother.
C/I: Hypersens.